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Episode 50: Sitting in Limbo 
Chris Dall: [00:00:00] Hi, everyone. Just a heads up that we have new Osterholm 
Update podcast and CIDRAP merchandise available on the MN alumni market website, 
including mugs, T-shirts and socks. You can find the link to that merchandise in the 
episode description. Now, here's this week's episode of the Osterholm Update. Hello 
and welcome to the Osterholm Update, covid-19, a weekly podcast on the covid-19 
pandemic with Dr. Michael Osterholm. Dr. Osterholm is an internationally recognized 
medical detective and director of the Center for Infectious Disease Research and Policy, 
or CIDRAP, at the University of Minnesota. In this podcast, Dr. Osterholm will draw on 
more than 45 years of experience investigating infectious disease outbreaks to provide 
straight talk on the covid-19 pandemic. I'm Chris Dall, reporter for CIDRAP News, and 
I'm your host for these conversations. It's April 8th, and across the country, millions of 
Americans every day are getting their first or second doses of covid-19 vaccine, the 
weather is getting warmer, signs of spring are popping up everywhere and the light at 
the end of the tunnel is getting a little brighter every day. At the same time, a surge of 
infections fueled by the B117 variant is gathering steam in the US following a regional 
pattern that we've seen play out before in this pandemic. And the worsening global 
spike in infections is raising the specter of new and even more dangerous coronavirus 
variants popping up and prolonging the pandemic. So for many of those who have been 
fully vaccinated or between doses, it feels like, as Jimmy Cliff once sang, sitting in 
limbo. How much longer will I have to wear a mask? Is it safe to travel or go eat at a 
restaurant? What can I feel safe doing and when can I feel safe doing it? We'll address 
some of these questions on this episode of the Osterholm Update as we look at the 
current state of the pandemic in the United States and around the globe. We'll also 
answer a listener question on vaccine passports and highlight the latest act of kindness 
from one of our Osterholm Update listeners. But first, as always, we'll begin with Dr. 
Osterholm's opening comments and dedication. 
 
Michael Osterholm: [00:02:11] Thank you, Chris, and welcome to all of you back to 
another episode of the podcast update. We are so pleased that you could be with us. 
And as I said each week, we so appreciate you spending your time with us. We know 
you have many other places to go and get your information. And we appreciate sharing 
with you this experience. For all of you who have submitted really wonderful questions 
and comments, very thoughtful ones, I regret that we can't address all of them each 
week. And, you know, we could probably extend this to about 12 hours and we might 
start getting to most of them. And I know right now that I keep stretching the limits and 
the staff, keep saying don't talk so much, keep it a little bit less verbose. But that 
happens. And so we don't want to stretch it out any longer. But I want to just say right 
now, I'm really sorry that we can't address more of your comments with us. As Chris 
opened the podcast today, he noted that he felt somewhat like the Jimmy Cliff song 
Sitting in Limbo. And you're going to hear that from me throughout the duration of this 
podcast episode. There's a lot that I wish we knew more about, I wish we were further 
along in where we want to be. And the uncertainty of what that next step might look like 
is surely a challenge. And this virus obviously occupies the waking hours, and in some 
cases, I think the dreaming hours of many of us here at CIDRAP. And we surely think 
about these issues and we'll give you our best shot and what they mean. Today's 
dedication is really one that has, in a sense, been addressed in the past, but not in its 
entirety. We realize that there are many, many people where you might say the silent 
supporters of our vaccine programs in this country. The people who give people rides, 
the people who help others get online and find a vaccine appointment date, people who 
are there not to do the vaccination of itself, but make it possible with the vaccinations 
could occur. And so we want to dedicate this to all the vaccine-related team members, 
everyone. Whether it's just helping people in your neighborhood or friends and family 
get an appointment, making sure that people are able to get to the sites, reminding 
others it's your time to get your second dose. This podcast is dedicated to you. And of 
course, no opening would be complete without some mention of light. We sit here in 
April in Minnesota right now in the middle of April showers. And I'm looking forward to 
the greening that's occurring right now with regard to that. But even though we love our 
April showers, oh, we love our April and May sun even more. And so today I'm very 
happy to report in Minneapolis/St. Paul that there are 13 hours and 9 minutes and 17 
seconds of sunlight today. We've increased 21 minutes since last week and we've 
actually increased 4 hours and 23 minutes since the vernal equinox on March 20th. And 
we have a new addition to our sunlight measure today. This is courtesy of Patrick and 
Donna from Denver. And thank you very much for your very thoughtful comment. They 
have shared with us that the sun angle in the sky right now in Minneapolis is that 54.44 
degrees at noon compared to 25.81 degrees on December 23rd, 2020. This is a very 
interesting way to look at it. It's not just the fact that we're getting sunlight, but where is it 
coming from? And many of us here are very aware of that very rapid sunset that occurs 
in the wintertime when the sun is so low to the horizon and how it stays and stays and 
stays in the summer when it's so high to the horizon. And thank you very much again to 
Patrick and Donna for this wonderful piece of information. As a reminder to all those in 
the Southern Hemisphere, we're shipping as much sunlight as we can and we look very 
forward to the reciprocity that will occur for us next December. 
 
Chris Dall: [00:06:40] So let's talk about what's going on in the United States right now. 
Michigan on Monday reported more than 11,000 new infections, which is higher than 
the peak they saw in November. And it's expected this is primarily being driven by B117. 
So, Mike, we're seeing rising cases in many other states right now, but is Michigan an 
outlier in terms of how hard it's getting hit or are there going to be more Michigan's? 
 
Michael Osterholm: [00:07:05] Chris, this is the 64 trillion dollar question, and let me 
just give you some context to that and then I'll answer the question with my best shot. 
First of all, let me just again celebrate what's happening with the vaccine program in the 
United States. My hat's off to all of those involved, particularly at the federal government 
level that are working so closely with the private sector manufacturers to get vaccine 
out, to get it distributed to those, as I pointed out earlier, who make it possible to get 
people vaccinated. And this in itself is a microcosm of the issue of the disease 
occurrence, i.e. a good news/bad news kind of situation. The good news is, it maybe 
great news, is that, in fact, as of Tuesday of this week, 32.6 percent of the entire US 
population had had at least one dose of vaccine and 19 percent were fully vaccinated. 
Now, you could look at that in the contrast and say 81 percent of the U.S. population 
has not had full vaccination yet. And in fact, almost 67.4 percent of the US population 
has not had at least one dose yet. Let's take a look at the age group that we have been 
most concerned about with regard to infection, serious illness and hospitalization and 
even potentially death. 56.6 percent of those who are 65 years of age and older have 
been vaccinated. 75.9 percent have received at least one dose. That still leaves about 
13 million individuals 65 years of age and older who have not yet been vaccinated and 
B117 is on top of us right now. So this is a challenge. We've now seen this number 
increase by about five and a half percent in the last 10 days. That's great in terms of the 
one dose issue. But just reminding ourselves that we still have got a ways to go to 
protect this population. Now, in terms of the issues around vaccine, and will that be 
enough together with previous infections, to protect us from a potential fourth surge, as 
it's now being called by so many? And the answer is absolutely it will not. It will not. I 
know I have colleagues and friends who continue to say that. The proof is already here. 
This isn't something that we have to debate. It's happening. Let me just, before I get into 
specific examples of why I say it's already happening, let me just give a very quick 
update on where we are nationwide. Cases in the US have risen by about 20 percent 
over the last 14 days. Clearly, we're no longer just in that trough, we're going up. While 
deaths have decreased by 24 percent over the past 14 days, we'll come back to that 
because that is a lagging indicator that we've talked about many times. Hospitalizations 
have increased about 2 percent over the past 14 days. Nationwide, we're seeing a 
divergence in the rate of hospitalizations by age. As I will point out, we have seen 
increases in 20 to 29 year old age groups and we've also seen increases in 40 to 49 
year old age groups. If you look at the states right now, including the District of 
Columbia, where cases are higher and staying high, we're at 28. States where cases 
are higher, but going down one, South Carolina. States where cases are lower, but 
going up five. And states where cases are lower and staying low, 17. Now, if you look at 
that, the states where cases are lower and going up, five. States are lower, staying low, 
17. That's twenty two states. You can say, wait a minute, it's kind of, you know, half the 
country is low, half the country's high. How can you make any sense of this? And what it 
is it's the tale of two cities. And this is something I've been talking about on this podcast 
for months. Remember, very briefly, after last April when we saw kind of the house on 
fire in New York City and parts of the northeast, we saw Chicago, Detroit, Atlanta, New 
Orleans, parts of Southern California really light up, some in the northwestern part of the 
country. We then emerged into what I would call the covid-19 regional pattern, where if 
you look in the upper Midwest around Memorial Day, we saw case numbers go up, 
surely not dramatically like we did later. But that was kind of that moment when you 
might say the back porch was on fire, not the house on fire. But then as those cases 
came down in mid-June to late June, suddenly the states from Southern California all 
the way to Georgia and South Carolina lit up. And that's when we hit the 70,000 cases a 
day, far, far exceeding even the 32,000 cases a day in April. And we saw limited activity 
in the Northeast and the upper Midwest at that time. Cases dropped in September to 
about 26,000. And then, lo and behold, the upper Midwest again led the way in October 
into early November such that by November 20th we hit 200,000 cases a day in this 
country. And a number that was unimaginable back in April. And it was driven by the 
upper Midwest. At one time North Dakota and South Dakota had the highest rates of 
disease incidence in the world. Well, those numbers dropped. By December 1st into 
that first week of December, we saw about 160,000 cases a day. And then guess what? 
The Southern states lit up again. From California all the way to Georgia, South Carolina, 
with the exception, interestingly enough, of New Mexico. We saw this major increase in 
cases and we hit 300,000 cases a day on January 6th. And then the cases dropped 
precipitously. This is that big drop that everyone assumes we had happen because of 
what we did in terms of mitigation. As you know, I don't believe that's true. I think that 
we surely have had an impact on the height of these curves, but it goes up and comes 
down Mother Nature is doing and we have to be humble enough to understand that. 
Why do I say that? Because I feel like we're in a deja vu all over again moment. The 
upper Midwest and the Northeast are lighting up and I think it's going to be just a matter 
of time before we see the rest of the country go through that same pattern. This time 
we're dealing with a different virus and it's a virus that's a much, much more dangerous 
virus than we've had already. And it's hard for most people to even imagine that 
because what we had before was really, really bad. And so now we're in this kind of tug 
of war between more people getting vaccinated every day, people already having been 
infected having immunity such that we are having a smaller and smaller proportion of 
our population who are vulnerable to this virus. But I believe in most areas of the 
country, we are still seeing upwards of 50 percent of the population still susceptible to 
this virus, even with what we've got with vaccine campaigns going on. Let me just 
illustrate that point in what's happening. Michigan really has become, I think, the first 
shot across the bow, it's not going to be the last. If you look at what's happening, their 
cases have continued to rise quickly in the state with a seven day average of 6,720 
cases a day. They estimate that about 70 percent of these cases are due to B117. That 
virus, which is 50 to 100 percent more transmissible, 60 to 70 percent more likely to 
cause severe disease, that's the virus we're dealing with. Today, the Michigan numbers 
have continued to climb prior to what we've been seeing in Michigan over the course of 
the last week. Their peak activity occurred on December 3rd at 8,291. And we're back 
there again. That's what we're seeing. On Tuesday, they had a much higher number in 
the 10000 range, which, of course, was the two day total from the weekend. But the 
point is, is that they are seeing this very substantial growth. In terms of outbreaks 
reported in the state, they continue to show substantial activity in educational settings. 
Of the 287 outbreaks reported in the past week, 81 were in schools, the highest number 
for all the listed settings. So amongst all the settings, school is still the predominant 
place for an outbreak. An additional 29 outbreaks were found in child care youth 
programs. As of this time, the state has 704 ongoing outbreaks and 220 are in K 
through 12 schools. Hospitalizations have increased by 108 percent over the past 14 
days. The state is reporting now more than 3,000 hospitalizations. One month ago now, 
there were 874 hospitalized people. Today, again, we're at 3,000. The Michigan Health 
and Hospital Association reports that among those aged 30 to 39, there were 26 daily 
admissions based on the seven day average during the fall. So remember that, 30 to 39 
there were 26 daily admissions during the seven day period when they had the fall 
peak. Today there were 43 admissions in the same age bracket. So you can see they've 
already surpassed in these younger ages the case numbers that are occurring in these 
younger age brackets. In terms of the 40 to 49 year old age bracket, we're seeing a 
similair rise. 58 patients being admitted daily compared to 33 during the big autumn 
surge that they had. For those 60 and older, the good news is hospitalizations have 
declined sharply as vaccinations have risen. So what we're really up against right now is 
what is happening in these younger age populations in terms of cases and disease 
severity and how much increased severity will occur among more enhanced 
transmission that will offset what gains we've made with vaccination in the older 
populations. In vaccinations, this is where some of my critics have said, you know, 
you're blowing steam, vaccines are going to take care of this. Michigan right now, 35.2 
percent of their population has had at least one dose. That compares to my home state 
here in Minnesota, which is doing a great job of 32 percent. 21.5 percent of the 
Michigan population are fully vaccinated. That compares to our 21 percent here in 
Minnesota. Don't tell me that previous infections as the Detroit area had seen two 
waves of infection that were quite substantial over the course of last April and last fall, 
as well as now having a remarkably high level of vaccination and look what they're 
seeing as we speak. So if you need to have even one counterpoint to say we're not 
going to be saved from this surge by vaccination, please understand, if we had three 
more months to get people vaccinated, we can have a very different picture, but we 
don't. It's like the old line from Secretary of Defense Donald Rumsfeld, who once said, 
"You don't get to go to war with what you want, you go to war with what you have." And 
right now, this is all we have. Now, if you look at the rest of the country, the CDC variant 
update, as reported as of April 5th, B117 now accounts for 15,511 cases in 52 different 
jurisdictions. That compares to the B1351, the variant that we had seen as a significant 
one in South Africa, 374 cases in 33 jurisdictions. And P1, the one that was first 
identified in South America there was two 289 cases in 25 jurisdictions. So if you look at 
15,500 versus 1350 or almost 300, B117 still is the predominant virus that we have to 
deal with. Let me just comment briefly on the regional trends. These are 14 day 
changes. And if you look at the states that have had at least 50 new cases per hundred 
thousand population in the past week, you've already commented on Michigan. 
Minnesota is up, cases are up 35 percent, hospitalizations 37 percent. Our positivity 
rate is now at 6.8 percent. We are not far behind what's been happening in Michigan. 
Let me go through the list just quickly. Nebraska, Illinois, North Dakota, Ohio, Iowa, all 
have more than 50 new cases per hundred thousand. And they're all seeing increases 
between 24 and 82 percent in new cases. If you look at two states in the Midwest that 
have just below the 50 new cases per one hundred thousand, but they're increasing 
substantially, Indiana's up 26 percent, Wisconsin is up 24 percent. Let me move to the 
east, northeast. That area that I said was also affected outside of the upper Midwest. If I 
look at the daily average above 50 new cases per hundred thousand residents in the 
past week, so they have to have at least 50 new cases per hundred thousand residents. 
New Jersey's up six percent. New York as a state is up 34, Rhode Island up 8. You'll 
see Pennsylvania up 44, Connecticut 25. I could go down the list. All of these are up 
substantially from where they were just one week ago. If you look at this right now, of 
the 27 states in the country that have had a daily average of 50 new cases per hundred 
thousand residents for the past week have seen these increases, 21 of these 27 states 
are in this area. This really is supporting the point I was making about the same pattern 
that we see. So if you don't see cases in California, you're not seeing big increases in 
Texas, you're not seeing big increases in these states in the south, wait. Just wait. And 
that, I think, is the message we have to get across. What we're doing is still fighting this 
virus in every state. And so how we deal with what's happening with openings, how we 
deal with how we get vaccine out, please understand that Michigan and Minnesota and 
the states that I just mentioned are not somehow outliers. This is what the country will 
see. And we've been through enough times that I would hope my colleagues would see 
that. And again, if you need any evidence that, in fact, vaccine in and of itself will not 
hold the surge down, just look at Michigan. And we're seeing the same thing in 
Minnesota right now. So hopefully this puts some exclamation point to what we're up 
against. This fourth surge is real. It is going to happen. Vaccines are going to have a 
very positive impact on reducing the number of cases in the older population. But 
they're not going to stop them. And we're going to continue to see this expansion of 
illnesses, some very serious hospitalizations, ICU care needs and even deaths in this 
much younger population. And kids are playing a very important role in the 
epidemiology of this transmission now. They are not getting infected any more 
frequently than adults, but they are getting infected what appears to be at the same rate 
now, which was different from before, and they are transmitting the virus. Those are the 
data. And we have to understand that's what we're up against right now. One additional 
point that I'd like to add about understanding cases in the United States is what's 
happening with testing. We are hearing from many, many locations that testing has 
dropped substantially because of the need to pull people out of the testing environments 
into the vaccination environments. And I don't know how much of testing decreases 
right now can be accounted to that or how much is just less activity out there. But even 
our own state of Minnesota, where we see the increasing number of cases occurring, 
when we were testing back during our fall surge in November, on November 27th we 
were testing over 800 people per 10,000 residents a day. Today, that's down to 374 per 
10,000 residents per day. It's less than half. And one of the challenges we have is that 
trying to understand the epidemiology of this disease, the testing issue could be a 
significant factor in case counts. So it's also one of the areas, I think, that we need to 
look at carefully of how do we measure what's going on? And I think ultimately 
hospitalizations and deaths are going to get to become a very, very key piece of what 
we're looking at. 
 
Chris Dall: [00:24:50] The uptick in US cases appears to be bringing more people 
around the idea of delaying the second dose of the vaccine in order to get first doses 
into more arms, an idea that you've been promoting for months now. Mike, do you 
sense some momentum on this issue? And would delaying second doses going forward 
have any impact on this fourth surge? 
 
Michael Osterholm: [00:25:11] Anyone who's been listening to this podcast for the past 
several months knows that this has been a particularly difficult issue for me, because 
every day that we don't act on this, we lose another day of providing people with 
potentially a lifesaving vaccine. And all before, of course we're talking about this surge, 
occurs with B117. Just to refresh everyone's memory, you know, originally in early 
February, our group put forward a paper with a number of other notable public health 
scientists and researchers indicating that the data were compelling that a single dose of 
either Pfizer or Moderna vaccines provided at least 80 percent or more protection well 
into days, weeks and months after the first dose. And that right now, what would be 
really important, is to get as many first doses into people as possible, anticipating this 
B117 surge. And it's one that is, you know by listening to this, that I've been anticipating 
for several months. We didn't do that. And today the data are compelling. The CDC 
itself has put out an article in the past 10 days noting their study found 80 percent 
protection plus for those who had a single dose of Pfizer vaccine after several weeks, 
90 percent plus for those that had two doses. Now, if you want to protect the most 
number of people, you could look at this very simple math and just come to your own 
conclusions. It doesn't take any rocket science to do this, even I can figure it out. That 
is, if I vaccinate one person with two doses and get 90 percent protection, the second 
person doesn't get a vaccine then because there's none there. The average protection 
is 90 plus zero divided by two, forty five percent. On the other hand, if I give each 
person one dose and it's 80 percent, that's 80 percent protection for the two of them. 
Now, you don't have to be a rocket scientist to understand that that's probably what you 
ought to consider doing. And when you look at what's been done in England and the 
remarkable outcome they've had a single dose, you see the increasing number of 
publications coming out showing modeling that supports this very much, including one 
that even looked at the potential for variant development, which had been a criticism 
saying, "Well, there won't be enough antibody there after one dose and these variants 
will start to develop." The Brits found none of that. None of that. And this most recent 
modeling paper didn't either. And so I haven't given up yet. We have literally lost five 
plus weeks, if not more, of where we could have been vaccinating 1.3 to 1.6 million 
additional people a day. Remember, when we hear these numbers too, about how 
many people are being vaccinated, they're actually misleading. Not because anybody is 
attempting to mislead you, but think about the fact that most of the vaccine being 
delivered today is the two dose Moderna or Pfizer vaccines. It's not J&J. They have not 
yet been able to deliver on large quantities of vaccine. Every time you hear someone 
saying we've just vaccinated three million people today, it's really 1.5 million people who 
got dose one, and 1.5 million people who got dose two. It's not new people who got that 
last 1.5 million doses. So we're still going to be far, far short of trying to deal with this 
B117 surge. And again, look at what's happening in Michigan and Minnesota. I wish we 
had a lot more vaccine. So I still haven't given up on this issue. I do think the southern 
states that I just laid out that are vulnerable to this, that are going to be coming over the 
weeks ahead, we could still do that. And remember, we're not asking anybody not to get 
a second dose. We're saying merely postpone it. So when you sign up for your second 
appointment, you don't sign up for it 3 weeks later or 4 weeks later, you sign up for it 10 
weeks later or 12 weeks later, without any reason to worry that your protection is going 
to wane substantially during that time. But imagine getting that, twice as many people 
vaccinated. So I think at this point, the number of people who have come forward 
publicly has been remarkable. Some really esteemed colleagues have come forward 
and said, "We need to do that." The US government's continued response is, via the 
media,  "Nope, we're not going to." And I just you know, I talk to these, these are my 
colleagues. I think the world of them, they're dear friends. But the fact that the US 
government has not done a formal review of this, I think is really their darkest hour in 
terms of what they've done with this program. So as much as they've done so much, so 
much, good. And they have really managed the vaccine stocks and getting them out in 
such a wonderful way. But just remember, only 19 percent of individuals in this country 
are fully vaccinated at this point. Only 32.6 percent have even had a single dose. So at 
this point, we need so much to expand on protecting these 20, 30, 40 year olds. I wish I 
could protect kids, we don't have a vaccine for that. And so am I hopeful? I don't know. 
This is not a rational situation from my perspective. Why would you not even look at this 
when other countries in the world have and come up with very different conclusions and 
the data surely support doing it? 
 
Chris Dall: [00:30:47] Mike, can you give our listeners a quick update on the global 
situation? 
 
Michael Osterholm: [00:30:52] Well, I come back to just the straightforward, honest 
assessment that this is the darkest hour of our pandemic. As much as people don't want 
to hear that, as much as they think this is an exaggeration, let me just give you the 
numbers. This past week, we reported over 4 million new cases to the World Health 
Organization with an increase of over 200,000 plus cases. If you look at where we've 
been, we were at 5 million cases reported a week at the surge in early January and then 
by early February that number dropped down to 2.4 million cases reported per week. 
Here we are now at 4 million cases and rising. Within the next two to three weeks, going 
to surpass the 5 million cases reported per week mark. We're seeing major upticks in 
cases around the world, and it really just bears the fact that in this case, we believe that 
the variants are playing a very, very key role. If you look at Europe, France continues to 
see high levels of cases and rising hospitalizations prompted another 4 week national 
lockdown, closing schools, non-essential businesses and banning nonessential travel. 
While cases are declining in Hungary, Poland and Estonia, each of these still remain in 
the top five worldwide for the number of reported cases per capita. As you know, 
Germany is also facing pressure to implement more nationwide restrictions in response 
to growing cases and severely challenged hospital care delivery situations. Moving to 
South America, Brazil is still facing major challenges related to the high levels of covid 
cases and the struggling health care system. They're seven day average for new daily 
deaths in the country recently exceeded 3000. That would surpass the US record high 
of 3285 cases, but remember, Brazil only has two thirds the population we have. So 
imagine what that means. P1, the variant P1 is still being considered the major variant 
responsible for much of Brazil's recent surge. And it's surely, right now the ICU capacity 
there, has been severely challenged with major oxygen supply shortages. Chile has 
implemented a nationwide lockdown in response to record high cases and immense 
pressure on the health care system. They have one of the highest vaccination rates in 
the world, administering 58 doses per hundred people to this point. 37 percent of the 
population has had one dose, 21 percent are fully vaccinated, basically exceeds our 
levels. Now, they have been using, however, the Sinovac vaccine from China and some 
have said, "Well, that vaccines are not as good." When you look at what we're using 
right now for Johnson and Johnson and you look at the WHO having just certified 
Sinovac as a vaccine to be used by countries, I think it's very important that we look at 
this carefully in terms of the vaccine, but I don't think there's any evidence right now that 
somehow there's been a big challenge to vaccine protection that has resulted in this 
situation. Other parts of the world, Asia and the Middle East, 11 countries in Asia and 
the Middle East are now reporting peak case numbers. India this week reported 
115,000 in a single day, the highest daily total to date. Cases are continuing to increase 
substantially in Iran and Turkey, with major upticks in cases and increase in deaths. 
Finally closer to home, Canada. Canada has experienced a rise in cases with variants 
playing a role, a major role. Cases and hospitalizations are increasing in Ontario, where 
more than 2000 B117 cases have been detected just in the last several weeks. It's 
leading to many more restrictions in the country. More restrictions have also been 
implemented in Quebec, which also is reporting an increase in cases and 
hospitalizations. And now British Columbia is seeing a rise in both B117 and P1 cases, 
something we're watching very, very carefully. B117 still makes up the majority of the 
variants of concern identified in British Columbia. But the province's reportedly detected 
480 cases of P1, with many of the cases tied to an outbreak at a ski resort in Whistler. 
In addition, the NHL Vancouver Canucks are suspected to have been impacted by the 
P1 variant, with more than half the team being isolated or quarantined due to covid 
protocols. The team hasn't played a game in two weeks, and reports indicate that a 
number of the players and staff tested positive, while some are considered very ill. So I 
think you can see that this is just continuing out there. And it really points out why we 
say this is the darkest hour of the pandemic. If you add these case numbers up, it's 
worse than we've seen any time in the past year. And so we're up against that as a 
country in terms of the pressure of cases occurring throughout the rest of the world. 
 
Chris Dall: [00:36:06] Earlier this week, members of the Lancet Covid-19 Commission 
Task Force on Public Health wrote an article arguing that the global rollout of vaccines 
was not enough at the moment to control variants of concern and that a strategy of 
maximum suppression was needed. Mike, do you agree? And what exactly would a 
strategy of maximum suppression look like? 
 
Michael Osterholm: [00:36:27] This has been a point that I've covered in previous 
podcasts and one that I don't think I can yell loud enough or, you know, stand tall 
enough to get people to understand just how critical this piece is. First of all, let's just 
take the immediate situation. As of this past week, more than 673 million doses of 
vaccine have been delivered in 155 different countries. Now, that sounds like great 
news, but that's just 4.4 percent of the global population. And if you look at where these 
vaccines have been delivered, 10 countries account for about 80 percent of the vaccine 
use. 30 countries have not even seen a drop of vaccine. There have been marked 
regional disparities in the number of countries who have already received or 
administered any doses, including Africa and Central Asia. Why do I raise this? 
Because, again, this is not just a humanitarian issue, that it is. Covax was set up to try 
to help respond to that. And yet, as an organization, its goal is, at best, to get potentially 
20 percent of low and middle income country residents a dose of vaccine or two. And 
now we recognize the challenge of trying to address the variant development, when, in 
fact, we have potentially billions of people who are still at risk of getting infected with this 
virus. And now Mother Nature's opportunity here through evolution, people getting 
infected, viruses mutating to produce new variants is kind of mind boggling. So I worry 
very, very much about our vaccine security for the world, specifically the high income 
countries, and of course the low income countries, if we're seeing these variants 
continue to be spit out with widespread, unfettered transmission in low and middle 
income countries. What does that mean for us? And what does it mean for our 
vaccines? I mean, look at where P1 came from, it came from South America. Look 
where we see B1351 coming, it came from South Africa. Now grant you, B117 came 
from the United Kingdom, it looks like. But from a standpoint of development of these 
variants, it's going to be the low and middle income countries. So I agree 
wholeheartedly with the thrust of that statement about why we have to rethink how we're 
going to try to protect these countries. Incremental response won't make it. We're in a 
war with this virus. We need to get on a war footing. What's it going to take to 
manufacture enough vaccines and support the infrastructure to get most of the world 
vaccinated in the shortest period of time as possible? And then to be able to keep up 
with any new vaccines that need to come out as a response to what's happening with 
variants? I don't see that grand plan. I don't see it coming from anybody. And I think that 
that's the challenge we have right now. We will be penny wise and pound foolish if we 
don't do everything we can to deal with the transmission of covid-19 virus in the low and 
middle income countries. 
 
Chris Dall: [00:39:51] So as I noted in the introduction, there are a lot of questions right 
now about what we can feel safe doing in this partially vaccinated world, and that's the 
focus of our listener question this week. This question actually came to us in late 
January when vaccines were still in short supply, but I think it applies to the current 
moment. Garda in western New York wrote, "There's so much talk about the vaccine 
shortage. This fosters an expectation that when vaccinated, we can have our lives back, 
yet there is no clear assurance. Am I free after my second vaccination or am I free after 
everyone's vaccination? Also, is there info on a vaccine passport for travel?" So, Mike, 
you used an analogy this past weekend on Meet the Press to explain how people 
should view being vaccinated in this current moment. Does that analogy help answer 
the first part of this question? 
 
Michael Osterholm: [00:40:42] Yes, I think it does. What we're really talking about here 
is not inconsistent between saying once you're vaccinated, your life will begin to open 
up in a new way. At the same time, you still want to be guarded and protect yourself. 
The analogy I used was imagine you have a fireproof suit, something that is there to 
protect you should you come in contact with fire. People who do fire suppression and 
respond to forest fires, fireperson's etc., all deal with this. But you know what? Those 
suits are not one hundred percent. There are places that you can still get burnt in your 
face, but they're really good. They're really good. Well, vaccines are like that, they're 
ninety/ninety five percent effective. And that's really, really good. But do you want to go 
walking in the middle of a hot, hot wildfire to test it out, to see how well that ninety, 
ninety five percent protection works? I don't think so. And in a sense, what we're talking 
about, when there's widespread virus transmission in the community, it doesn't mean 
that your vaccine is not important. It's potentially a real lifesaver for many, but it doesn't 
mean it will protect everyone all the time. So what CDC was saying, for example, in 
travel this past week was, yeah, now you can be free to go travel, but if you don't have 
to, if it's non-essential, why don't you wait right now because all that fire is out there. 
And why put yourself in harm's way? Now if it's essential, you have to go, something's 
happened, you got a lot of protection, go for it. So I think that what we're trying to get 
across to people is as we get more and more people vaccinated or unfortunately 
infected and have protection from natural immunity, that level of virus transmission in 
the community will continue to drop. And now you may be walking in a one foot high 
grass fire where you will be protected in that suit completely as opposed to a raging out-
of-control forest fire where that suit may not protect you. That's our vaccines, and I look 
forward to the day when we have a six inch high grass fire and I'll feel really good about 
my suit. But until then, I'm going to make every effort to still limit my potential for 
transmission. You will not get me into a restaurant right now. You won't. I think this is a 
huge challenge. You know, there is a number of things like that I won't go to right now, 
even though, you know, I've got my vaccine just because I don't want to test that 
vaccine knowingly. And so hopefully this will give people a sense that time is coming 
where you will have more and more opportunities to be in the public setting feeling 
really, really good about it when the virus activity level drops and your vaccine is on 
board. 
 
Chris Dall: [00:43:48] Ok, into the second part of Gardas question vaccine passports. 
There's been a lot of discussion around this idea. What are your thoughts on vaccine 
passports? 
 
Michael Osterholm: [00:43:57] Well, let me just say at the outset, they're going to 
happen. They are going to happen. Number two, we don't have a clue yet necessarily 
how to do it and the challenges. When we think about passports, we're thinking about a 
very legitimate need to say we want like people to be able to be together. If I do go into 
a restaurant or go to a concert or I have kids in schools or I have any number of 
business related activities, can I be in the same room as someone who is also 
vaccinated, fully vaccinated, as am I, and feel really confident about being there? If I'm 
in a restaurant where I know that everyone in there has a passport, will I feel better 
about going to that place or a concert or whatever? I think the answer is yes. And 
people want that. So they're going to happen. It's going to happen with transportation. 
You know, I willingly gave up my eyeball scan and my fingerprints to Clear so I could 
get on and off planes quickly. I haven't used it for a while, but, you know, it's there. And 
so people are going to want to do this. The problem we have are several fold. One is, 
what does immunity mean? What is a correlate of protection? Meaning, is it a certain 
level of some kind of antibody? What test do you use to show that? Is it, 'I had my 
vaccine'? We know we have vaccine failures, but maybe just being vaccinated with two 
doses of X, how do I make sure that that's been proven, that that's me? And so one of 
the challenges we're going to have is just how do we define what protection is? And 
know that this is solid evidence, this is inferred evidence, this is no evidence? What 
does that mean? So that's number one. Number two is how do you do it? Right now, 
Israel is doing it with paper largely. Will it be paper? Will it be electronic? You know, the 
challenge I think we're going to have is then how does that fit into the data that we so 
cherish about our health care system? Why have the electronic medical record been 
such a challenge for so long? Because of people's concerns about privacy and how 
data might be shipped between a private company and a government agency or 
something like that. Those are all challenges. And then how often do you have to keep 
this information up? Let's say I do achieve a certain antibody level from having 
previously been infected or I have evidence of two vaccines, when do I need to update 
that? Will I need to update that? Will it wane? And so at this point, just stay tuned. 
There's going to be a lot more coming. The Biden administration has made it clear that 
they will help provide guidance for electronic passports, but they're not going to do 
them. This is going to be an effort that is still really, I think, going to be a challenge. In 
the March 31st issue of the New England Journal of Medicine, Mark Hall and David 
Stuttert, published a very thoughtful paper, "Vaccine Passport" Certification- Policy and 
Ethical Considerations. And they lay out in really very clear terms the kind of challenges 
that we have about the issue of electronic or paper passports for any kind of covid-19 
certification. Whether or not there will be ethical issues because some people will have 
access to these certificates and others won't, just because of availability for vaccine or 
financial considerations. They list a number of different issues here. And I think that one 
of the key issues is also distinguishing a passport from a mandate. In other words, no 
one has to get a passport. But if you want one, then by obtaining that, that may give you 
a privilege, grant you, to get into certain venues, to use certain transportation modes, 
etcetera. And to me, I don't find that as a problem, if, in fact, it means some people 
aren't excluded because they can't afford it, they can't get access to it. The 
confidentiality is going to be huge. And we're going to see more and more discussions 
about that, how to do it. If this were easy, it would have been done already in terms of 
electronic medical records. Does information get given to someone else? I'm aware of 
one particular group that was working with homeless people in a community where 
because they were bouncing from emergency room to emergency room, they got them 
an electronic record note that allowed them when they came into any emergency room 
for the medical care team to quickly pull up the records and understand what was going 
on. Well, there was a change in administration and all those data were given to ICE. 
And when that happened, it killed the program just like that. So we're going to have to 
look at the kind of social/political issues that come up with this. But I'm confident, I'm 
confident that this can happen. All I can say is stay tuned. There is currently a network 
of tech companies called the Covid-19 Credentials Initiative that is trying to set a 
standard for vaccine certificates. While the Commons Project, a non-profit, is working 
with the World Economic Forum on a digital health pass that's been going through trials. 
And some of you may be aware of this right now, there's actually one being used in the 
state of New York as an experiment at this point. So I will keep you posted as we learn 
more here about what's happening with these passports, how they might work. 
Understanding Israel right now has, what they call, a green pass being used. What does 
that mean? And stay tuned. But right now, there's nothing imminent, I think, on a 
nationwide basis for a passport. 
 
Chris Dall: [00:50:04] Now to our latest act of kindness, this comes from a listener 
email we received, and while it wasn't labeled as an act of kindness, it certainly struck 
us as one. Mike, can you share with the audience? 
 
Michael Osterholm: [00:50:17] Well, I think this act of kindness really also is linked 
closely to the earlier listener question about what can I do or can't do? This act of 
kindness is one that I hope spreads more than any weed could ever do. It's one that we 
need to see it around the world as the opportunity presents itself. This comes from 
Carolyn. Carolyn is a veterinarian and obviously a very, very special person. She wrote. 
"Hi, Team Osterholm/CIDRAP, I thought you'd enjoy hearing about this. My niche as a 
veterinarian is to provide hospice and home euthanasia for companion animals. As you 
can imagine, doing this work in a loving yet safe manner has been a challenge this past 
year. A few days ago, I had just helped a woman say goodbye to her beloved cat. 
During our brief encounter, I had learned that all her loved ones had moved far away 
and it had been just her and the cats for some time. As we parted ways, she patted me 
awkwardly on the shoulder and said, 'I guess we can't hug'. It broke my heart not to give 
this lovely person what used to be such a routine gesture of comfort. But then as I 
opened my car door, I shouted back to her. 'Wait a minute, are you vaccinated?' She 
said she was. So I said, 'Me too. Let's hug.' And we embraced wholeheartedly in the 
street next to my car. Since being vaccinated, I haven't changed my behavior at all, I've 
been wearing PPE and practicing social distancing all along. I felt so incredibly grateful 
to be able to make a brief exception for someone who truly needed it. Vaccines are 
miraculous. I look forward to the podcast every week. Thanks for what you are doing. 
Carolyn." Carolyn, you're a miracle. You're an example. I hope everyone finds that like 
individual out there who is also vaccinated, and as you feel appropriate to hug and as 
the other person does too, please do it. Please touch. Please share that relationship 
that unfortunately we've almost thrown away, as we discarded the horse and buggy. 
This is something we can't do, and this vaccine empowers us to do that. I am so grateful 
that you sent this beautiful piece and it touched me immensely because unfortunately, I, 
too, have used the services of veterinarians such as yourself for my beloved dogs. I'll 
never forget the kindness, the professionalism, the support that these very, very special 
veterinarians provided at a time of great pain. And so for you to be able to do this just is 
a classic example of what we're trying to promote here. How we can get through this 
pandemic using every opportunity we have on our side to make it a better world. And 
you did. Thank you so much, Carolyn. 
 
Chris Dall: [00:53:35] Your closing thoughts today, Mike? 
 
Michael Osterholm: [00:53:38] Well, thank you again for staying with us through this 
podcast this far. As we talked about at the very beginning, we're in limbo. We are 
watching cases continue to unfold in this country. And I am afraid that people are 
convinced that what is about to happen is not going to happen. And we're living our lives 
as such. And I keep saying this week after week after week, and I can't say it with any 
more conviction and belief that please, please do not let yourself be the person who 
dies three days before they were scheduled to get their covid vaccine. We can do this, 
we can get through. This surge is not going to be pretty, but it does not have to 
consume any of us if we just hold out a little bit longer. This virus can't get through brick 
walls. It can't leap tall buildings in a single bound. It won't seek you out when you're 
protecting yourself. And that's what we have to do to get through. And we have to help 
other people understand that. The next thing I just wanted to comment on was, I can't 
tell you the feedback that I got this past week from the letter that I read last week from 
Teresa Thayer Snyder. I've had more requests for this letter to be sent to someone, 
even though it was available on the podcast site. And the reason was, is that not only 
did it touch a nerve about who our kids are, but it said so much about who we are as 
parents, who we are as the guardians of our children, who we are as the ones bringing 
up the next generation. And as much as we want our teachers and our educational 
communities to be skilled professionals, we want them to do the one thing they do best 
of all, that is, love our kids. They love them. And I think that this letter really, really hit 
that note in a time of a pandemic, how do we most effectively protect and support our 
kids. So I just want to again thank Teresa for the opportunity to use this letter. You 
know, from my last week's discussion, she's something. She's really something. And I 
have such respect and admiration for her. Which leaves me with my last final quote. 
Today, I'm going to leave you with something that I've used before, the golden oldie, a 
treasure chest comes back again. On August 13th, which was our first live episode 
recorded between episodes 19 and 20, I closed the program with this final quote from 
Edward Everett Hale. As you may recall, for those of you who listen to this podcast, 
Edward Everett Hale was an American author, historian, Unitarian minister, best known 
for his writing, such as The Man Without a Country. He was born in 1822, died in 1909. 
And this quote that I use from him is as follows: "I am only one, but still I am one. I 
cannot do everything, but still I can do something. And because I cannot do everything, 
I will not refuse to do something that I can do." That's us right now. That's everyone on 
this podcast. That's our families, that's the people we work with. This is the people we 
love. We can do things right now to protect ourselves, to get through this next surge. 
One, is we don't deny its existence. We anticipate it. Two, we continue to understand 
that much brighter days are ahead. And three, we remain committed to getting through 
this pandemic, in such a way that we do it with class, we do it with goodness, kindness 
and patience. This is what it's all about. You don't have to do everything, but you can 
still do something. And just as you heard a couple of minutes ago, Carolyn did just that. 
She didn't do everything. But you know what? She did something really, really special. 
So I leave you with that sense that now is our time. Now is our time to actually get 
through this last few weeks and now is our time to help others get through this 
pandemic as much as we're helping ourselves. So please be kind. Be patient. Make 
certain that you take care of yourself, be good to yourself. And thank you so much for 
spending time with us again. Our entire podcast family here at CIDRAP cannot fully 
explain to you how much we appreciate your input, your kindness, your thoughts. They 
mean everything to us. We're so, so fortunate to be a part of your lives and to have you 
be part of ours. Thank you. Be kind. 
 
Chris Dall: [00:58:46] Thanks for listening to this week's episode of the Osterholm 
Update. If you're enjoying the podcast, please subscribe, rate and review and be sure to 
keep up with the latest covid-19 news by visiting our website CIDRAP.umn.edu. The 
Osterholm Update is produced by Maya Peters, Cory Anderson and Angela Ulrich. 
 
